相关实验视频
Updated: Sep 16, 2025
11:42
Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
Published on: July 10, 2017
11.8K
在JAK2-变体基本血小板血中出血并发症:2025年重新访问
Gerard Gurumurthy1, Samantha Gurumurthy2, Tim C P Somervaille3,4
1The University of Manchester Manchester UK.
EJHaem
|July 8, 2025
概括
矛盾的是,基本血栓塞血症 (ET) 可以导致由于获得的·维勒布兰德综合征 (AvWS) 的出血. JAK2-V617F突变增加了出血风险,需要谨慎管理以平衡血栓形成和出血风险.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 内部医学 内部医学
背景情况:
- 基本血小板血 (ET) 是一种由高血小板计数定义的骨髓增殖性瘤.
- 流血并发症是ET患者的一个重要,但经常被忽视的临床问题.
- 与CALR突变相比,患有JAK2-V617F突变的患者可能有更高的出血风险.
研究的目的:
- 为了研究基本血栓细胞血症中出血并发症背后的机制.
- 探索获得的·威尔布兰德综合征 (AvWS) 和血小板功能障碍在ET相关出血中的作用.
- 讨论ET中AvWS的诊断方法和术后管理策略.
主要方法:
- 对有关ET,JAK2-V617F突变和出血的临床观察和文献的审查.
- 在血栓细胞形成的背景下,分析获得的·威尔布兰德综合征 (AvWS) 的病理生理学.
- 讨论VWF异常的诊断测试和临床管理策略.
主要成果:
- 在ET中获得的威尔布兰德综合征 (AvWS) 与极端的血小板数量有关,导致VWF多分子蛋白解,模仿2A型威尔布兰德病.
- 发展AvWS的血小板计数值是可变的,即使在1000 × 10 ^ 9 / L以下也会出现显著的VWF异常.
- 患有JAK2-V617F突变的ET患者可能更容易因AVWS和血小板功能障碍而出血.
结论:
- 在ET中出血的风险,特别是在JAK2-V617F阳性患者中,通常与获得的·维勒布兰德综合征 (AvWS) 相关.
- 诊断AvWS依赖于VWF测试,管理需要平衡抗血栓和静血需求.
- 量身定制的患者管理对于减轻基本血栓细胞血症中出血和血栓事件至关重要.
相关概念视频
01:24Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
02:45Blood Transfusion and Agglutination
11.3K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.3K
01:20The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
9.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.3K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
919
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
919
01:25Endocarditis II: Clinical Features of Infective Endocarditis
28
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
28